Vaccine maker BioNTech to use mRNA tech to target malaria ...Middle East

Chron - News
Vaccine maker BioNTech to use mRNA tech to target malaria
BERLIN (AP) — Pharmaceutical company BioNTech said Monday that it wants to use the mRNA technology behind its coronavirus vaccine to target malaria. The Germany-based company, which developed the first widely approved coronavirus shot together with U.S. partner Pfizer, aims to begin clinical trials for a “safe and highly effective malaria vaccine” by the end of next year. “We are already working on HIV and and tuberculosis, and malaria is the third big indication (disease) with a high unmet medical need,” BioNTech's chief executive, Ugur Sahin, told The Associated Press. “It has an incredible high number of people being infected every year, a high number of patients dying, a particularly se

Hence then, the article about vaccine maker biontech to use mrna tech to target malaria was published today ( ) and is available on Chron ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Vaccine maker BioNTech to use mRNA tech to target malaria )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News